265
Views
1
CrossRef citations to date
0
Altmetric
Letters

Complementology’s foundation: The 100-year anniversary of the Nobel Prize to Jules Bordet

&

References

  • Lahaie, Y.-M.; Watier, H. Contribution of Physiologists to the Identification of the Humoral Component of Immunity in the 19th Century. mAbs. 2017, 9(5), 774–780. DOI: 10.1080/19420862.2017.1325051.
  • Crist, E.; Tauber, A. I. Debating Humoral Immunity and Epistemology: The Rivalry of the Immunochemists Jules Bordet and Paul Ehrlich. J. History Biol. 1997, 30(3), 321–356. DOI: 10.1023/A:1004269605715.
  • Waksman, B. H.;. A Comparison of the Von Krogh Formula (Logistic Function) and the Method of Probits as Applied to Hemolysis by Complement. J. Immunol. 1949, 63(4), 409–414.
  • Carroll, M. C.; Duncan Campbell, R.; Bentley, D. R.; Porter, R. R. A Molecular Map of the Human Major Histocompatibility Complex Class III Region Linking Complement Genes C4, C2 and Factor B. Nature. 1984, 307, 237–241. DOI: 10.1038/307237a0.
  • Katalinić, N.; Starčević, A.; Mavrinac, M.; Balen, S. Complement-dependent Cytotoxicity and Luminex Technology for Human Leucocyte Antigen Antibody Detection in Kidney Transplant Candidates Exposed to Different Sensitizing Events. Clin. Kidney J. 2017, 10(6), 852–858. DOI: 10.1093/ckj/sfx050.
  • Thurman, J. M.; Michael Holers, V. The Central Role of the Alternative Complement Pathway in Human Disease. J. Immunol. 2006, 176(3), 1305–1310. DOI: 10.4049/jimmunol.176.3.1305.
  • Lambris, J. D.; Ricklin, D.; Geisbrecht, B. V. Complement Evasion by Human Pathogens. Nat. Rev. Microbiol. 2008, 6(2), 132. DOI: 10.1038/nrmicro1824.
  • Atkinson, J. P.; Du Clos, T. W.; Mold, C.; Kulkarni, H.; Hourcade, D.; Wu, X. The Human Complement System: Basic Concepts and Clinical Relevance. In Drs. Robert R. Rich, Thomas A. Fleisher, William T.Shearer, Harry W. Schroeder, Jr., Anthony J. Frew, and Cornelia M.Weyand (Eds.,) Clinical Immunology (Fifth edition) Principles and Practice, 2019; pp 299–317.
  • Nesargikar, P. N.; Spiller, B.; Chavez, R. The Complement System: History, Pathways, Cascade and Inhibitors. Eur. J. Microbiol. Immunol. (Bp). 2012, 2(2), 103–111. DOI: 10.1556/EuJMI.2.2012.2.2.
  • Heidelberger, M.; Mayer, M. M. Quantitative Studies on Complement Book. In Edited by F. F. Nord. Book Series:Advances in Enzymology - and Related Areas of Molecular Biology; 71–115. 1948. Interscience Publishers, Inc.
  • Li, C. K.;. Proof of the One-hit Mechanism of Complement-induced Lysis. Immunochemistry. 1975, 12(1), 89–92. DOI: 10.1016/0019-2791(75)90054-3.
  • Nilsson, U. R.; Müller-Eberhard, H. J. Studies on the Mode of Action of the Fifth, Sixth and Seventh Component of Human Complement in Immune Haemolysis. Immunology. 1967, 13(1), 101–117.
  • Daniel Ricklin, E. S.; Reis, D. C.; Mastellos, P. G.; Lambris, J. D. Complement Component C3 – The “Swiss Army knife” of Innate Immunity and Host Defense. Immunol. Rev. 2016, 274(1), 33–58. Special Issue: Preformed Mediators of Defense.
  • Maves, K. K.; Weiler, J. M. Properdin: Approaching Four Decades of Research. Immunol. Res. 1993, 12, 233. DOI: 10.1007/BF02918255.
  • Michelle Elvington, M.; Liszewski, K.; Atkinson, J. P. Evolution of the Complement System: From Defense of the Single Cell to Guardian of the Intravascular Space. Immunol. Rev. 2016, 274(1), 9–15. DOI: 10.1111/imr.12474.
  • Chakraborti, S.; Ram, S. Complement, in Management of Infections in the Immunocompromised Host. In Segal, B. H., Ed.; Springer Nature, 2018; pp 55–93. DOI: 10.1016/j.ecoenv.2018.11.122.
  • Kazatchkine, M.; Nydegger, U.; Hauptmann, G. Techniques Du Complément Editions; INSERM, 1985.Paris.
  • Levy, M.; Halbwachs-Mecarelli, L.; Gubler, M.-C.; Kohout, G.; Bensenouci, A.; Niaudet., P.; Hauptmann, G.; Lesavre, P. H Deficiency in Two Brothers with Atypical Dense Intramembranous Deposit Disease. Kidney Int. 1986, 30, 949–956. DOI: 10.1038/ki.1986.278.
  • Jlajla, H.; Dehman, F.; Jallouli, M.; Kallel-Sellami, M. Molecular Basis of Complement Factor I Deficiency in Tunisian Atypical Hemolytic and Uremic Syndrome Patients: CFI Deficiency in Tunisian Atypical Hemolytic and Uremic Syndrome Patients. Nephrology. 2018, 24(3), 357–364.
  • Dragon-Durey, M. A.; Blanc, C.; Roumenina, L. T.; Poulain, N.; Ngo, S.; Bordereau, P.; Frémeaux-Bacchi. Anti-factor H Autoantibodies Assay. Methods Mol. Biol. 2014, 1100, 249–256.
  • Dragon-Durey, M.-A.; Blanc, C.; Marliot, F.; Loirat, C.; Blouin, J.; et al. The High Frequency of Complement Factor H-Related CFHR1 Gene Deletion Is Restricted to Specific Subgroups of Patients with Atypical Haemolytic Uraemic Syndrome. J. Med. Genet. BMJ Publishing Group. 2009, 46(7), 447.
  • Sánchez-Corral, P.; González-Rubio, C. Rodríguez De Córdoba S, López-Trascasa M (2004) Functional Analysis in Serum from Atypical Hemolytic Uremic Syndrome Patients Reveals Impaired Protection of Host Cells Associated with Mutations in Factor H. Mol Immunol.41(1), 81–84. DOI: 10.1016/j.molimm.2004.01.003.
  • Morgan, B. P.;. CIinical Complementology: Recent Progress and Future Trends European. J. Clin. Incestigution. 1994, 24(2), 19–228.
  • Mastellos, D. C.; Ricklin, D.; Lambris, J. D. Clinical Promise of Next-generation Complement Therapeutics. Nat. Rev. Drug Discovery. 2019, 18, 707–729.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.